You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Pulmonology

On demand events

ERS 2022 | Keeping It Simple: Providing Precision Medicine to Adults With Severe Asthma

Join Profs. Oscar Palomares and Enrico Heffler as they discuss precision medicine for adults with severe asthma.

PhD

Oscar Palomares +1 more

On demand materials

ERS 2022 | Keeping It Simple: Providing Precision Medicine to Adults With Severe Asthma

Pulmonology

32 min

expert video

ERS 2022 | Keeping It Simple: Providing Precision Medicine to Adults With Severe Asthma

ERS 2022 | Predicting the Response: Using Type 2 Biomarkers to Navigate the Biologic Landscape in Adults With Severe Asthma

Pulmonology

24 min

expert video

ERS 2022 | Predicting the Response: Using Type 2 Biomarkers to Navigate the Biologic Landscape in Adults With Severe Asthma

ERS 2022 | Achieving Control Without Oral Corticosteroids: An Expert Review of Guideline-Driven Management of Adult Severe Asthma With Biologics

Pulmonology

8 min

expert video

ERS 2022 | Achieving Control Without Oral Corticosteroids: An Expert Review of Guideline-Driven Management of Adult Severe Asthma With Biologics

Learning objectives

Review the pathophysiology of type 2 inflammation in asthma and the role of type 2 inflammatory biomarkers in identifying disease
Evaluate the latest LTE, ITC, and OCS sparing data for the approved biologics in severe asthma

About these experts

Allergy/Immunology

PhD

Oscar Palomares

Complutense University of Madrid

Allergy/Immunology

MD, PhD

Enrico Heffler

Associate Professor of Internal Medicine and Consultant | Personalized Medicine Asthma and Allergy Unit, Humanitas University, Milan, Italy

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region